PLUR

Pluri Inc. PLUR

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode PLUR ANTX QTTB NXTC IBIO BOLD PSTV ITRM INTS SABS
6M -9.09 % 2.73 % 95.16 % 87.95 % 153.90 % 20.67 % 189.64 % -60.93 % 47.80 % 123.74 %
YTD -16.86 % -18.71 % -12.32 % 7.51 % -19.21 % -54.03 % -52.38 % -78.86 % -76.61 % 7.95 %
1Y -18.18 % -11.02 % -9.43 % -7.02 % -19.21 % -50.20 % -43.24 % -77.90 % -79.53 % 2.69 %
3Y -53.61 % -88.47 % -87.07 % -31.52 % -75.56 % 12 549 900.00 % -87.92 % -61.24 % -93.13 % -50.56 %
5Y -92.72 % -92.66 % -98.69 % -91.51 % -99.68 % 12 549 900.00 % -98.25 % -97.36 % -93.13 % -96.05 %
10Y -96.05 % -92.66 % -99.10 % -95.56 % -99.94 % 12 549 900.00 % -100.00 % -99.80 % -93.13 % -96.05 %
From the beginning -99.98 % -92.66 % -99.10 % -95.56 % -99.96 % 12 549 900.00 % -100.00 % -99.80 % -93.13 % -96.05 %

Dividend

AN2 Therapeutics, Inc.